Zhuoyi Bio
Zhuoyi Bio
Zhuoyi Bio

Step into Zhuoyi

International experts offer authoritative insights! Zhuoyi Bio made its debut at the Chongqing Rabies Conference, spearheading new trends in VVM label applications.

Release Date:

2025-05-12

         From May 8 to 10, 2025, the 2025 China Rabies Academic Conference was grandly held in Chongqing. Zhuoyi Biotechnology, one of China’s leading manufacturers of human rabies vaccines, was invited to attend. On the registration day, May 8, Zhuoyi Biotechnology welcomed its first wave of distinguished guests—vaccine experts and representatives from partner service providers from across the country—who arrived to check in and engage in discussions. The company’s staff extended a warm welcome, providing attendees with comprehensive conference materials and attentive, thoughtful services.

          At 6:00 p.m., Zhuoyi Bio has specially invited Durham University. Molecular Biology and Biochemistry Master’s degree holder and international vaccine expert Jon Pearman bring “The Significance of Using VVM Labels on Rabies Vaccines” Keynote address: an in-depth analysis of the revolutionary significance of VVM tags in vaccine safety.


 


 

International Perspective:

How to crack VVM Vaccine cold chain “Blind spot”?


 


 

 

  Jon Pearman, who has 17 years of experience in the vaccine industry, has previously worked at Johnson & Johnson, GlaxoSmithKline The Global Alliance for Vaccines and Immunization (Gavi), with a footprint spanning 73 countries, is an internationally recognized authority on vaccines. In his address, he cautioned: “Once rabies develops, the mortality rate is nearly 100%; timely and standardized post-exposure prophylaxis (PEP) can prevent death, making rapid access to vaccines of paramount importance.” If the cold chain fails, all efforts will be in vain.

Addressing this pain point, Jon Pearman elaborates on the core advantages of VVM tags:

Real-time monitoring: Based on the polymerization reaction of a diacetylene monomer, the vaccine’s stability is visually indicated by an irreversible color change from light to dark, enabling rapid assessment of its potency without the need for complex equipment.

Global Verification: Temptime produces more than 700 million VVMs annually. VVM is a technology recommended by the WHO (World Health Organization), ensuring quality throughout the entire vaccine supply chain—from manufacturing to administration.

Following the conclusion of the special session, Mr. Zhang Shifang, a marketing consultant, took to the stage to deliver a welcoming address. He extended his heartfelt greetings to the industry experts and partners who had traveled from afar, and wished all distinguished guests an enjoyable and productive two-day experience.


 


 

With technology as its shield, Zhuoyi Bio upholds its “Safety Commitment.”


 


 


 

Zhuoyi Biotechnology has been deeply engaged in vaccine R&D for two decades, consistently upholding “safety and efficacy” as the cornerstone of its product development. As China’s first company to win a bid for human rabies vaccines under the VVM specification category, and as the domestic pioneer to implement VVM labels on rabies vaccines, Zhuoyi Biotechnology remains committed to driving industry transformation through technological innovation.

The application of VVM tags can Further strengthen the stability of rabies vaccines during transportation and storage to ensure that each dose delivers its full potency to the recipient. It not only safeguards patients’ lives but also brings numerous conveniences to healthcare professionals.


 


 


 

Rooted in China, Engaging with the World


 


 

 

This international expert symposium not only underscores Zhuoyi Biotechnology’s commitment to aligning with global vaccine‑technology standards, but also, through the perspective of a reputable third party, validates the reliability of China‑made vaccine‑technology innovations. 
     Looking ahead, Zhuoyi Biotechnology will continue to advance the localized application of cutting-edge international technologies such as VVM, leveraging scientific innovation to safeguard health and well-being, and helping China’s rabies prevention and control efforts reach even higher standards.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home